Skip to main content
Clinical Trials/CTRI/2023/07/055250
CTRI/2023/07/055250Not yet recruitingUnknown

Establishing the application of Monocyte monolayer assay (MMA) in predicting the clinical significance of the red cell antibody. - NI

TERUMO PENPO0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • •Patient with auto or allo antibodies to red cell antigen and requiring
  • •best matched blood unit transfusion

Exclusion Criteria

  • •Patients with passively acquired antibodies
  • •Patients having alloantibodies with known specificity where phenotype matched
  • •blood units will be given to the patient

Investigators

Sponsor
TERUMO PENPO

Similar Trials